Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-Positive Early Breast Cancer × Trastuzumab × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 19 Colorectal Neoplasms 5 Stomach Neoplasms 4 Neoplasm Metastasis 4 Neoplasms 3 Multiple Myeloma 3 HER2-positive Breast Cancer 3 Endometrial Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Squamous Cell Carcinoma of Head and Neck 2 Salivary Gland Neoplasms 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Esophageal Neoplasms 2 Adenocarcinoma Of Esophagus 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Resectable HER2-positive Breast Cancer 1 Prostatic Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Neoplasm, Residual 1 Melanoma 1 Malignant Solid Neoplasm 1 Lymphoma 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡